You just read:

Mundipharma and Purdue Pharma Expand Pain Pipeline with New Deal for First-in-Class Sigma-1 Antagonist (S1A or MR309/E-52862) from ESTEVE

News provided by

Purdue Pharma L.P.

15 May, 2016, 19:30 ET